Search results
22 paź 2024 · Welcome to the Harvard-MIT Program in Health Sciences and Technology. Here, the next generation of clinician-scientists and engineers learns to harness the combined power of science, engineering, and medicine, to translate research findings into clinical practice, and to improve human health.
- Contact
Contact - Harvard-MIT Health Sciences and Technology
- Support HST
Support HST - Harvard-MIT Health Sciences and Technology
- Login
Login - Harvard-MIT Health Sciences and Technology
- Academic Programs
Academic Programs - Harvard-MIT Health Sciences and...
- MEMP
HST’s MEMP PhD Program Is this program a good fit for me?...
- Information for UROP Supervisors
Information for UROP Supervisors - Harvard-MIT Health...
- Registration
All HST students are required to register at MIT during each...
- Finding a Lab
Finding a Lab - Harvard-MIT Health Sciences and Technology
- Contact
Healthcare changes dramatically because of technological developments, from anesthetics and antibiotics to magnetic resonance imaging scanners and radiotherapy.
Founded in 1970, the Harvard-MIT Program in Health Sciences and Technology (HST) is one of the world’s oldest interdisciplinary educational programs focused on translational medical science and engineering.
22 lut 2023 · Healthcare innovation is accelerating at an unprecedented scale, particularly in the digital sphere, the World Health Organization says. Advances such as artificial intelligence and gene editing are transforming the way diseases are detected and treated. Here are 5 innovations that are pushing boundaries in healthcare.
3 paź 2023 · Exploring uncharted waters, the healthcare landscape in 2024 unveils transformative trends like generative AI, personalized medicine and IoT-powered virtual hospitals
Founded in 1970, the Harvard-MIT Program in Health Sciences and Technology (HST) is one of the world’s oldest interdisciplinary educational programs focused on translational medical science and engineering.
13 lut 2023 · The goal was to provide advice and guidance to federal agencies, scientists, and journals concerning oversight and public availability of research in biotechnology or biomedicine that has the potential to be a threat to public health, agriculture, the economy, or national security.